From: The epidemiological and economic impact of a quadrivalent human papillomavirus (hpv) vaccine in Estonia
Discounted total
Incremental
Costs/person (€)*
QALY/person (year)**
Costs/QALYs (€/year)***
No vaccination
126.29
27.09184
--
Routine vaccination
152.79
27.09726
26.5
0.00542
4889